ERBB2 and neoplasm: Additionally, tumor-infiltrating lymphocytes (TILs) are considered a marker of favorable prognosis and were associated with greater gut microbial diversity, particularly in HER2+ patients, and correlated with improved response to chemotherapy [41,79].